Beta-blockers after myocardial infarction.
Excellent recent trials have demonstrated beyond reasonable doubt that beta-blockade started during convalescence from confirmed myocardial infarction reduces mortality in the next year or two by about a quarter. Similar confidence does not extend to the mechanisms of action, choice of drug, defining treatment criteria in relation to severity and age, or to the duration of treatment.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010096:Oxprenolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013999:Timolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D013999:Timolol; D011433:Propranolol